Human medicines European public assessment report (EPAR): Calquence, acalabrutinib, Date of authorisation: 05/11/2020, Revision: 13, Status: Authorised | European Federation of Internal Medicine

Submitted by Anonymous (not verified) on 7 October 2026 - 14:25

Human medicines European public assessment report (EPAR): Calquence, acalabrutinib, Date of authorisation: 05/11/2020, Revision: 13, Status: Authorised

Link:

https://www.ema.europa.eu/en/medicines/human/EPAR/calquence

Source:

Newsletters

Stay informed on our latest news!

Latest Newsletters